Ojaswita, presently develops content for page125.org and a number of other similar platforms. Endowed with a prior experience of being a Technical Engineer, she now writes articles pertaining to business trends and the latest industry news. That apart, she loves to listen to music, craft, and cook in her leisure time. She can be contacted at- [email protected] | https://twitter.com/ojaswita_k
Swiss healthcare conglomerate, Roche AG’s Chinese arm Shanghai Roche Pharmaceuticals Ltd. has recently announced collaboration with biotechnology firm Ascletis BioScience Co., Ltd to expand their partnership on a pegylated interferon treatment (deemed Pegasys) for Hepatitis B and C starting December 2018. As per trusted sources, …
Silicon Valley’s data analytics firm, Palantir Technologies Inc., has recently announced plans to form a joint venture with German drug maker Merck KGaA to help advance cancer research, while it makes further inroads in the healthcare sector. As per sources, the collaboration (deemed Syntropy) will …
Pharmaceutical giants Fuji Pharma and Alvotech have recently announced that they are collaborating for the development and commercialization of biosimilars in Japan. Under the agreement, Alvotech will be looking after the development and supply of biosimilar assets, while Fuji Pharma will be taking control of …
Verily, the life sciences division of Google’s parent Alphabet, has recently announced that it has halted the development of a smart contact lens designed for helping to monitor sugar levels. It was one of the company’s oldest and most high-profile projects and had begun in …
British engineering conglomerate, Smiths Group plc has recently announced plans to spin off its medical devices division to focus on emerging as a dedicated industrial technology company. As per a statement, Smiths claims that the parting will allow the medical unit, which develops artificial hip …
Several healthcare insurers have reportedly decided to participate in a new-fangled federal government program intended to lessen the time duration between the actual coverage decision for the medical equipment and the FDA approval. Sources claim that the move has been initiated in a bid to …
St. Louis based Washington University’s researchers have reportedly established a new technique to overcome the blood-brain barrier (BBB), in a bid to administer medications to the brain. Sources familiar with the development claim that these medications would particularly heal brain tumors classified under the difficult-to-treat …
One of the largest pharmaceutical companies in the world, Merck & Co has reportedly gained approval for its cancer drug Keytruda to be officially used in the European countries. According to sources familiar with the development, the drug will be used in association with chemotherapy …
The tezepelumab therapy produced by pharmaceutical giants AstraZeneca and Amgen, has reportedly won the status of being a ‘breakthrough therapy’ in the United States owing to its potential to cure severe asthma, that too without the eosinophilic phenotype. According to sources familiar with the development, …
